Psilocybin

Screen Shot 2023-10-04 at 10.28.47 AM.png

News & Research

Screen Shot 2023-10-04 at 10.30.22 AM.png

Recent research from Imperial College and Kings College in London and Johns Hopkins in the US, are demonstrating that psilocybin along with other psychedelics have a valuable role in the treatment of mental health, combatting addictions and end-of-life distress.

In 2018 the FDA granted psilocybin and MDMA the status of a 'breakthrough therapy'. The state of Oregon legalised psilocybin in November 2020 for use in a therapeutic setting which paves the way for other states to follow. Australia has now legalised the use of Psilocybin.

Screen Shot 2023-03-13 at 3.46.21 PM.png

Screen Shot 2023-03-13 at 3.38.36 PM.png

Screen Shot 2023-03-13 at 3.39.47 PM.png

Screen Shot 2023-03-13 at 3.07.51 PM.png

Screen Shot 2023-03-13 at 2.59.47 PM.png

Screen Shot 2023-03-13 at 3.35.07 PM.png

Screen Shot 2023-03-13 at 2.44.59 PM.png

Screen Shot 2023-03-13 at 2.26.55 PM.png

Screen Shot 2023-03-13 at 2.46.02 PM.png

Screen Shot 2021-03-18 at 2.53.42 PM.png

Screen Shot 2020-12-02 at 10.07.53 AM.pn

Screen Shot 2020-12-02 at 6.08.43 PM.png

Screen Shot 2020-12-02 at 1.04.35 PM.png

Screen Shot 2020-12-02 at 1.08.25 PM.png

Screen Shot 2020-12-02 at 2.14.37 PM.png

Screen Shot 2020-12-02 at 1.15.29 PM.png

Screen Shot 2020-12-02 at 1.10.14 PM.png

Article by Carhart-Harris:

We can no longer ignore the potential of psychedelic drugs to treat depression

At Imperial College we’ve been comparing psilocybin to conventional antidepressants – and the results are likely to be game-changing.

The impact of successful psychedelic therapy is often one of revelation or epiphany. People speak of witnessing “the bigger picture”, placing things in perspective, accessing deep insight about themselves and the world, releasing pent-up mental pain, feeling emotionally and physically recalibrated, clear-sighted and equanimous.

Screen Shot 2020-10-28 at 10.00.38 AM.pn